Nature

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma

Sarah Bird is at the Institute of Cancer Research, London SM2 5NG, UK and at the Royal Marsden Hospital NHS Foundation Trust, London. Charlotte Pawlyn is at the Institute of Cancer Research, London ...
Science Daily

Gene-edited CAR-T cells erase aggressive T-cell leukemia

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...
New Scientist

'Weaponised' CAR T-cell therapy shows promise against solid tumours

Immune cells that have been genetically engineered to kill cancerous cells, known as CAR T-cells, have transformed the treatment of blood cancers such as leukaemia, but have proved largely ineffective ...
Fred Hutch

For many blood cancer patients, CAR T-cell therapy is game-changing

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...